OpenAI to Host First Developer Conference in San Francisco

France Nouvelles Nouvelles

OpenAI to Host First Developer Conference in San Francisco
France Dernières Nouvelles,France Actualités
  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 50%

OpenAI will host its first developer conference this fall, as the ChatGPT-maker looks to bolster interest in its products while facing growing competition from other artificial intelligence companies.

In a blog post Wednesday, the AI startup said it will hold the event, OpenAI DevDay, in San Francisco on Nov. 6. The company said it will host hundreds of developers from around the world, offering sessions with its technical staff and giving attendees a chance to look at the new tools it’s building. OpenAI also plans to livestream a keynote presentation.

With the event, OpenAI joins a long list of larger tech firms that host developer events to deepen ties with third-party app makers and also show off their product pipeline to a broader audience. OpenAI said more than 2 million developers use its GPT-4, GPT-3.5, Dall-E and Whisper AI models. Both GPT-4 and GPT-3.5 are used to operate ChatGPT. The company first rolled out its application programming interface, which developers can use to add its AI models to their apps, in 2020.

“We’re looking forward to showing our latest work to enable developers to build new things,” OpenAI Chief Executive Officer Sam Altman said in the blog post.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

BNNBloomberg /  🏆 83. in CA

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

OpenAI CEO Sam Altman First Person to Get Indonesian Golden VisaOpenAI CEO Sam Altman First Person to Get Indonesian Golden VisaOpenAI Chief Executive Officer Sam Altman is the first person to get an Indonesian golden visa as Southeast Asia’s largest economy seeks to draw foreign investors.
Lire la suite »

OpenAI CEO Sam Altman First Person to Get Indonesian Golden VisaOpenAI CEO Sam Altman First Person to Get Indonesian Golden Visa(Bloomberg) -- OpenAI Chief Executive Officer Sam Altman is the first person to get an Indonesian golden visa as Southeast Asia’s largest economy seeks to draw foreign investors. Most Read from BloombergHuawei Teardown Shows Chip Breakthrough in Blow to US SanctionsMercedes Bets on Range Boost in Swipe at Tesla’s EV LeadDiamond Prices Are in Free Fall in One Key Corner of the MarketStocks Cede China-Led Gains in Thin Holiday Trade: Markets WrapThe country’s immigration authority issued a 10-year
Lire la suite »

Video: OpenAI to reportedly make over $1-billion revenueVideo: OpenAI to reportedly make over $1-billion revenueOpenAI is on track to generate more than $1-billion in revenue over the next 12 months from the sale of artificial intelligence software and computing capacity that powers it, the Information reported on Aug 30.
Lire la suite »

Albemarle aims to close buyout of lithium developer Liontown by mid-2024Albemarle aims to close buyout of lithium developer Liontown by mid-2024(Reuters) - Albemarle aims to close its buyout of Australian lithium developer Liontown Resources by the middle of 2024, its chief executive said on ...
Lire la suite »

Eskom’s Ex-COO Moves From Coal to Renewables Developer MuliloEskom’s Ex-COO Moves From Coal to Renewables Developer MuliloJan Oberholzer, the former chief operating officer of Eskom Holdings SOC Ltd., has shifted focus from fixing coal-fired power plants to developing clean energy in a new role at South African renewables producer Mulilo Energy Holdings Ltd.
Lire la suite »

B.C.-founded biologics developer Tentarix raises US$35-million after securing Gilead dealB.C.-founded biologics developer Tentarix raises US$35-million after securing Gilead dealTentarix is developing biologic therapies that target specific cells in the body and could be used to fight cancer and autoimmune diseases while limiting side effects
Lire la suite »



Render Time: 2025-03-12 12:50:57